Welcome to Vol. 15, Issue No. 2 (MARCH 2016) of Pharma Marketing News. TV DTC, ad mascots, Off-label promotion.
This article summarizes various scenarios for how the FDA, courts, and independent 3rd-parties may influence off-label drug promotion in the future.
Welcome to Vol. 15, Issue No. 4 (September 2016) of Pharma Marketing News. This issue focuses on off-label promotions directed to consumers, dark and scary disease awareness advertising, and breakthrough cancer therapy DTC.
This article describes how Boehringer Ingelheim teamed up with with Univison in a ground-breaking campaign to drive awareness for Type 2 Diabetes through story-line integrations in the original production, Bajo el Mismo Cielo (Under the Same Sky).
This article summarizes the results of three surveys, which were presented at an FDA Part 15 hearing regarding 'Manufacturer Communications Regarding Unapproved Uses of Approved or Cleared Medical Products.'
Brand name drug mascots not only appear in TV and print ads, they also are plastered all over patient education brochures and other marketing pieces, on websites, and wherever else there are eyeballs! This article features our all-time favorite drug ad mascots.
This article is a review of the e-book entitled Pharma 3D: Rewriting the script for marketing in the digital age.
Welcome to Vol. 15, Issue No. 1 (JANUARY 2016) of Pharma Marketing News. New Drug Approvals, FDA Enforcement Actions, 2016 New Year's Resolution, and Digitally Savvy Women Pharma Pioneers are the themes of this issue.
The big jump in DTC advertising & high cost of drugs have resulted in calls for a total ban of DTC advertising or the elimination of tax deductions for DTC advertising. And the FDA is planning a bevy of studies, which may lead to new guidelines.
Instagram may become the social medium of choice for pharma marketers now that it has been purchased by Face-book and has added several new features that allow marketers to potentially thwart FDA regulations.